Time New York: Thu 28 May 12:00 pm  |  Save 15% on H&R Block Online


The Joint Corp. (JYNT) Dips More Than Broader Markets: What You Should Know


The Joint Corp. (JYNT) closed the most recent trading day at $15.94, moving -1.48% from the previous trading session. This change lagged the S&P 500′s daily loss of 0.16%. At the same time, the Dow lost 0.07%, and the tech-heavy Nasdaq lost 0.52%.

Heading into today, shares of the company had lost 16.73% over the past month, lagging the Medical sector’s gain of 4.4% and the S&P 500′s gain of 3.12% in that time.

Investors will be hoping for strength from JYNT as it approaches its next earnings release. Our most recent consensus estimate is calling for quarterly revenue of $11.06 million, up 46.35% from the year-ago period.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $0.22 per share and revenue of $46.38 million. These totals would mark changes of +450% and +45.89%, respectively, from last year.

Any recent changes to analyst estimates for JYNT should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 2.22% lower within the past month. JYNT is currently sporting a Zacks Rank of #3 (Hold).

Investors should also note JYNT’s current valuation metrics, including its Forward P/E ratio of 73.54. Its industry sports an average Forward P/E of 14.64, so we one might conclude that JYNT is trading at a premium comparatively.

Also, we should mention that JYNT has a PEG ratio of 7.35. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company’s expected earnings growth rate into account. Medical – HMOs stocks are, on average, holding a PEG ratio of 1.04 based on yesterday’s closing prices.

The Medical – HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 16, putting it in the top 7% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow JYNT in the coming trading sessions, be sure to utilize Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.